EUVIMEDEUVIMED entdecken
Crossref

PINK1 insufficiency can be exploited as a specific target for drug combinations inducing mitochondrial pathology-mediated cell death in gastric adenocarcinoma

Sayak Ghosh, Debapriya Ghatak, Rittick Dutta, Devyani Goswami, Rudranil De

Archives of Biochemistry and Biophysics · 2024-09 · 759 · 110110

DOI: 10.1016/j.abb.2024.110110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024-09. Verfasst von Sayak Ghosh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Biotechnology, Amity University Kolkata, Plot No: 36, 37 & 38, Major Arterial Road, Action Area II, Kadampukur Village, Newtown, K…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Mitochondria, Protein Kinases. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: India Ministry of Science & Technology Department of Science and Technology, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There exist very limited non-hazardous therapeutic strategies except for surgical resection and lymphadenectomy against gastric cancer (GC) despite being the third leading cause of cancer deaths worldwide. This study proposes an innovative treatment approach against GC using a drug combination strategy that manipulates mitochondrial dynamics in conjunction with the induction of mitochondrial pathology-mediated cell death. Comparative analysis was done with gastric adenocarcinoma and normal cells by qPCR, western blot, microscopic immunocytochemistry, and live cell imaging. In this study, impairment of dynamin-related protein 1 (Drp1)-mediated mitochondrial fission by Mdivi-1 created an imbalance in mitochondrial structural dynamics in indomethacin-treated AGS cells in which mitophagy-regulator protein PINK1 is downregulated. These drug combinations with the individual sub-lethal doses ultimately led to the activation of cell death machinery upregulating pro-apoptotic proteins like Bax, Puma, and Noxa. Interestingly, this combinatorial therapy did not affect normal gastric epithelial cells significantly and also no significant upregulation of death markers was observed. Moreover, the drug combination strategy also retarded cell migration and reduced stemness in GC cells. In summary, this study offers a pioneering specific therapeutic strategy for GC treatment, sparing normal cells providing opportunities for minimal drug-mediated toxicity utilizing mitochondria as a viable and specific target for anti-cancer therapy in gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaMitochondriaProtein KinasesHumansCell Line, TumorIndomethacinMitochondrial DynamicsDynaminsApoptosisMitophagyCell DeathAntineoplastic AgentsQuinazolinonesPTEN-Induced Putative Kinase

Stichwörter der Autor:innen

Gastric adenocarcinomaMitochondriaMitochondrial dynamicsMitophagyPINK1

Substanzen

Protein KinasesIndomethacinDynaminsAntineoplastic AgentsQuinazolinonesPTEN-Induced Putative Kinase3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinoneDNM1L protein, human

Autor:innen und Institutionen

  • Amity Institute of Biotechnology, Amity University Kolkata, Plot No: 36, 37 & 38, Major Arterial Road, Action Area II, Kadampukur Village, Newtown, Kolkata, 700135, West Bengal, India.
  • Indian Association for the Cultivation of Science, Jadavpur, Kolkata, 700032, West Bengal, India.
  • Swami Vivekananda University, Kolkata, 700121, West Bengal, India.
  • Amity Institute of Biotechnology, Amity University Kolkata, Plot No: 36, 37 & 38, Major Arterial Road, Action Area II, Kadampukur Village, Newtown, Kolkata, 700135, West Bengal, India. Electronic address: drudranil@kol.…

Förderung

  • India Ministry of Science & Technology Department of Science and Technology
  • Science and Engineering Research Board

Zitieren

APA

Ghosh, S., Ghatak, D., Dutta, R., Goswami, D., & De, R. (2024). PINK1 insufficiency can be exploited as a specific target for drug combinations inducing mitochondrial pathology-mediated cell death in gastric adenocarcinoma. Archives of Biochemistry and Biophysics, 759, 110110. https://doi.org/10.1016/j.abb.2024.110110

Vancouver

Ghosh S, Ghatak D, Dutta R, Goswami D, De R. PINK1 insufficiency can be exploited as a specific target for drug combinations inducing mitochondrial pathology-mediated cell death in gastric adenocarcinoma. Archives of Biochemistry and Biophysics. 2024;759:110110. doi:10.1016/j.abb.2024.110110

BibTeX
@article{Ghosh2024,
  author = {Ghosh, Sayak and Ghatak, Debapriya and Dutta, Rittick and Goswami, Devyani and De, Rudranil},
  title = {PINK1 insufficiency can be exploited as a specific target for drug combinations inducing mitochondrial pathology-mediated cell death in gastric adenocarcinoma},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2024},
  volume = {759},
  pages = {110110},
  doi = {10.1016/j.abb.2024.110110}
}
Kostenlos starten →